Clinical Trials Directory

Trials / Completed

CompletedNCT00080158

Treatment of Adolescent Suicide Attempters (TASA)

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
120 (planned)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.

Detailed description

Suicide is the third leading cause of death in adolescents and is a major public health problem. Depression is the most common diagnosis for adolescent suicide attempts. Little is known about what treatment is best for these adolescents since they are usually excluded from participation in research studies. Participants in this study will be randomly assigned to receive carefully monitored antidepressant medication with routine support and management, cognitive behavioral therapy (CBT), or a combination of antidepressant medication plus CBT.

Conditions

Interventions

TypeNameDescription
DRUGfluoxetine
DRUGsertraline
DRUGcitalopram
DRUGescitalopram
DRUGbupropion
DRUGmirtazapine
DRUGvenlafaxine
DRUGlithium
BEHAVIORALCognitive Behavioral Therapy

Timeline

Start date
2004-03-01
Completion
2007-06-01
First posted
2004-03-26
Last updated
2020-06-22

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00080158. Inclusion in this directory is not an endorsement.